Illumina, Inc., and Nashville Biosciences, LLC (NashBio), announced Alnylam Pharmaceuticals, Inc. (Alnylam) as a member of the Alliance for Genomic Discovery (AGD). Alnylam, a pioneer in RNA ...
A judge in New York rejected a request on 23 September to disqualify the use of cutting-edge DNA sequencing as evidence in a case against an alleged serial killer. The ruling paves the way for a type ...
SAN DIEGO - Alnylam Pharmaceuticals (NASDAQ:ALNY), a $59.29 billion market cap biotechnology company with impressive year-to-date returns of 92%, has become the ninth member of the Alliance for ...
Applied Digital said it will cover the costs to build the bypasses and turn lanes needed for trucks to drive into the data center site. A mockup of Applied Digital’s 280-megawatt data center, or AI ...
Prime Medicine (NASDAQ: PRME) has had a lot to celebrate in recent months, explaining a surge that has seen the prime editing therapy developer’s stock more than double this year, including a 22% jump ...
Alnylam has also joined the Alliance for Genomic Discovery, a move aimed at advancing RNA interference therapies using a comprehensive clinical genomic database for drug target discovery. Additionally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback